SCHEMBL4247141

SCHEMBL4247141

CNS(=O)(=O)c1ccc(C(O)C2CCN(C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.58
MMP13 P45452 7/20 0.56
STS P08842 6/20 0.54
MMP1 P03956 3/20 0.54
MMP3 P08254 3/20 0.54
MMP7 P09237 3/20 0.54
MMP9 P14780 3/20 0.54
MMP8 P22894 3/20 0.54
MMP2 P08253 2/20 0.54
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
EED O75530 1/20 0.48
RBBP4 Q09028 1/20 0.48
SUZ12 Q15022 1/20 0.48
EZH2 Q15910 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4236812 0.87 GPR119 (0.63) GPR119MMP13
SCHEMBL4169879 0.81 GPR119 (0.62) GPR119MMP13STSMMP1MMP3
SCHEMBL4239889 0.81 ALDH1A1 (0.52) GPR119MMP13NPC1ALDH1A1MAPT
SCHEMBL4244525 0.81 ALDH1A1 (0.52) GPR119MMP13NPC1ALDH1A1MAPT
SCHEMBL4240647 0.81 ALDH1A1 (0.52) GPR119MMP13NPC1ALDH1A1MAPT
SCHEMBL4393991 0.81 MMP13 (0.55) GPR119MMP13NPC1ALDH1A1MAPT
SCHEMBL2520399 0.81 ALDH1A1 (0.55) GPR119STSNPC1ALDH1A1MAPT
SCHEMBL22558670 0.81 GPR119 (0.59) GPR119MMP13STSMMP1NPC1
SCHEMBL1405370 0.81 GPR119 (0.59) GPR119MMP13STSMMP1NPC1
SCHEMBL4248552 0.80 ALDH1A1 (0.61) GPR119MMP13STSMMP1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491735-B2 Chemokine receptor binding compounds GENZYME CORPORATION (US) 2009-02-17 US disclosed
EP-1708703-A4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2008-04-09 EP disclosed
EP-1708703-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-10-11 EP disclosed
US-20050277670-A1 Chemokine receptor binding compounds ANORMED INC. 2005-12-15 US disclosed
WO-2005059107-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277670-A1 Chemokine receptor binding compounds CCR5, CXCR3, CCL5 GPR119 207/4885MMP13 1839/4885STS 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.